查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1086202

静脉注射用溶液的美国市场:各溶液类型，各包装型态(安瓿，管瓶，滤芯，瓶，袋子)，各适应症，各终端用户 - 规模，占有率，预测，机会分析(2022年～2028年)

U.S Intravenous Solution Market, by Solution Type, By Packaging (Ampules, Vials, Cartridges, Bottles, Bags, By Indication, and By End User - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格
简介目录

烧烫伤治疗管理所使用的静脉注射用溶液，有蛋白质为基础的胶体，高渗液，等渗压晶质液等。因为美国烧烫伤的发生数量增加，预计该市场在预测期间内扩大。

本报告提供美国的静脉注射用溶液市场相关调查分析，市场动态，各市场区隔的市场分析，各地区的市场分析，竞争情形等相关的系统性资讯。

目录

第1章 调查目的、前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概要

  • 报告的说明
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各溶液类型
    • 市场明细:各袋子类型
    • 市场明细:各用途
    • 市场明细:各终端用户

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的发展
  • 法规情形
  • 流行病学分析
  • 波特的五力分析

第4章 美国的静脉注射用溶液市场:各溶液类型(2017年～2028年)

  • 简介
    • 市场占有率分析:2022年、2028年(%)
    • 与前一年同期比较成长分析:2017年～2028年
    • 市场区隔趋势
  • 生理食盐水
    • 简介
    • 市场规模、预测，与前一年同期比较成长率(2017年～2028年)
    • 通常生理食盐水(0.9% NaCl)
    • 高渗食盐水
  • 聚葡萄糖
  • 乳酸林格氏液
  • 氨基酸
  • 维生素和矿物质
  • 肝素、微量矿物质
  • 混合溶液

第5章 美国的静脉注射用溶液市场:各袋子类型(2017年～2028年)

  • 简介
    • 市场占有率分析:2022年、2028年(%)
    • 与前一年同期比较成长分析:2017年～2028年
    • 市场区隔趋势
  • 高容量袋子(250ml以上)
    • 简介
    • 市场规模、预测，与前一年同期比较成长率(2017年～2028年)
  • 少容量袋子(不满250ml)

第6章 美国的静脉注射用溶液市场:各用途(2017年～2028年)

  • 简介
    • 市场占有率分析:2022年、2028年(%)
    • 与前一年同期比较成长分析:2017年～2028年
    • 市场区隔趋势
  • 基本IV溶液
    • 简介
    • 市场规模、预测，与前一年同期比较成长率(2017年～2028年)
  • 营养IV溶液
  • 血液IV溶液
  • 药物IV溶液
  • 清洗IV溶液

第7章 美国的静脉注射用溶液市场:各终端用户(2017年～2028年)

  • 简介
    • 市场占有率分析:2022年、2028年(%)
    • 与前一年同期比较成长分析:2017年～2028年
    • 市场区隔趋势
  • 医院
    • 简介
    • 市场规模、预测，与前一年同期比较成长率(2017年～2028年)
  • 诊所
  • 门诊病人手术中心

第8章 竞争情形

  • 企业简介
    • Baxter International Inc.
    • ICU Medical, Inc.
    • B. Braun Melsungen Ag
    • Grifols, S.A.
  • 分析师的见解

第9章 Section

简介目录
Product Code: CMI3400

Intravenous solutions are supplemental fluids used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route of administration is not possible in an individual. Intravenous therapy is a medical technique that delivers fluids, medications and nutrition directly into a person's vein. Intravenous solution therapy is an efficient and effective way of supplying fluids directly into the intravascular fluid compartment of the body. Intravascular fluids are used to replace electrolyte losses, and also for administering medications and blood products. Intravenous solutions are also known as Intravenous fluids. Some of the major reasons when patient needs to take fluids intravenously, rehydration after becoming dehydrated from illness, treatment of an infection using antibiotics, cancer treatment through chemotherapy drugs, management of pain using certain medication. Fluids for such treatments consists of water with electrolytes, sugar, or medications. The amount of intravenous solution can be regulate in the body by two ways, manually or by using electric pump, which uses a pump to regulate intravenous fluid. Types of intravenous solutions are saline, dextran, lactated Ringer's, amino acid, vitamins & minerals, heparin and trace elements and mixed solutions.

Market Dynamics

The intravenous solutions used during burn care management are protein-based colloids, hypertonic solutions, isotonic crystalloids, and others. The increasing number of burn incidences in the U.S. is expected to boost the U.S. intravenous solutions market over the forecast period. For instance, according to the Burn Association of America, approximately 486,000 fire or burn injuries were reported at emergency departments in 2016 in the U.S.

However, growth of the U.S. intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in August 2015, Covidien LLC, recalled their product Monoject 0.9% Saline Flush Prefill Double Pouch over the packaging process control reason. As there was defect in packaging of monoject 0.9% saline flush pouch.

Key features of the study:

  • This report provides an in-depth analysis of global U.S intravenous solution market, provides market size (US$ Million), and compound annual growth rate (CAGR %), for the forecast period (2022 - 2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
  • It profiles key players in the U.S intravenous solution market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study are B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA, LLC, Grifols, S.A., JW Life Science, Amanta Healthcare, Salius Pharma Private Limited, Axa Parenterals Ltd., Vifor Pharma Management Ltd., Icu Medical, Inc., and Pfizer Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The U.S intravenous solution market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for dialysis market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • U.S Intravenous Solution Market, By Solution Type:
    • Saline
      • Normal Saline (0.9% NaCl)
      • Hypertonic saline
    • Dextran
      • D5W (5% dextrose in water)
      • Analog Hypertonic Saline
    • Lactated Ringer's
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and trace elements
    • Mixed Solutions
  • U.S Intravenous Solution Market, By Packaging Type:
    • Ampules
    • Vials
    • Cartridges
    • Bottles
    • Bags
      • Large Volume Bags (greater than 250ml)
      • Small Volume Bags (less than 250ml)
  • U.S Intravenous Solution Market, By Indication:
    • Oncology
    • Post-Operative Care
    • General Medicine
    • Burn Management
    • Pulmonary Disorders
    • Cardiovascular Diseases
    • Others
  • U.S Intravenous Solution Market, By End User:
    • Hospitals
      • Clinics
      • Ambulatory Surgery Centres
      • Home care Settings
      • Others
  • Company Profiles
    • B. Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Baxter International Inc.
    • Fresenius Kabi USA, LLC
    • Grifols, S.A.
    • Jw Life Science
    • Amanta Healthcare
    • Salius Pharma Private Limited
    • Axa Parenterals Ltd.
    • Vifor Pharma Management Ltd.
    • Icu Medical, Inc.
    • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Solution Type
    • Market Snippet, By Bag Type
    • Market Snippet, By Application
    • Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Landscape
  • Epidemiology Analysis
  • Porter's Five Forces model

4. U.S. Intravenous Solutions Market, By Solution Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Saline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Normal Saline (0.9% NaCl)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Hypertonic Saline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Dextran
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Lactated Ringer's
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Amino Acid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Vitamins & Minerals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Heparin and trace elements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Mixed Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. U.S. Intravenous Solutions Market, By Bag Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Large Volume Bags (greater than 250ml)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Small Volume Bags (less than 250ml)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. U.S. Intravenous Solutions Market, By Application, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Basic IV Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Nutritional IV Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Blood IV Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Drug IV Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Irrigation IV Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. U.S. Intravenous Solutions Market, By End User , 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Home care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Competitive Landscape

  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ICU Medical, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • B. Braun Melsungen Ag
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Grifols, S.A.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact